These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35950248)

  • 1. Pain Allaying Epalrestat-Loaded Lipid Nanoformulation for the Diabetic Neuropathic Pain Interventions: Design, Development, and Animal Study.
    Vishwakarma VK; Paswan SK; Arora T; Verma RK; Yadav HN
    Curr Drug Metab; 2022; 23(7):571-583. PubMed ID: 35950248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions.
    Visnagri A; Kandhare AD; Chakravarty S; Ghosh P; Bodhankar SL
    Pharm Biol; 2014 Jul; 52(7):814-28. PubMed ID: 24559476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.
    Jaiswal S; Mishra S; Torgal SS; Shengule S
    Life Sci; 2018 Aug; 207():364-371. PubMed ID: 29936149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
    Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
    J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects of Isolated Mangiferin from
    Shivam ; Gupta AK
    Cent Nerv Syst Agents Med Chem; 2024; 24(2):182-195. PubMed ID: 38305392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of mildronate on peripheral neuropathy and some characteristics of glucose and lipid metabolism in rat streptozotocin-induced diabetes mellitus model].
    Sokolovska J; Rumaks J; Karajeva N; Grīnvalde D; Shapirova J; Kluša V; Kalvinsh I; Sjakste N
    Biomed Khim; 2011; 57(5):490-500. PubMed ID: 22629599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic effect of olive leaf extract on streptozotocin-induced diabetes mellitus in experimental animals.
    Gürbüz M; Öğüt S
    Nutr Hosp; 2020 Oct; 37(5):1012-1021. PubMed ID: 32960633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats.
    Taliyan R; Sharma PL
    Inflammopharmacology; 2012 Apr; 20(2):89-97. PubMed ID: 22179948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysin loaded nanovesicles ameliorated diabetic peripheral neuropathy. Role of NGF/AKT/GSK-3β pathway.
    El-Marasy SA; AbouSamra MM; El-Mosallamy AEMK; Emam AN; Mabrok HB; Galal AF; Ahmed-Farid OA; Abd El-Rahman SS; Moustafa PE
    Chem Biol Interact; 2023 Apr; 375():110402. PubMed ID: 36804429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats.
    Yu J; Zhang Y; Sun S; Shen J; Qiu J; Yin X; Yin H; Jiang S
    Can J Physiol Pharmacol; 2006 Jun; 84(6):579-87. PubMed ID: 16900242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beraprost sodium, a prostacyclin analogue, on tail flick response in two models of diabetic-neuropathy in rats and its mechanism.
    Ueno Y; Koike H; Annoh S; Nishio S
    Life Sci; 1996; 59(9):PL105-10. PubMed ID: 8761032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy.
    Hotta N; Kawamori R; Fukuda M; Shigeta Y;
    Diabet Med; 2012 Dec; 29(12):1529-33. PubMed ID: 22507139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diosgenin ameliorates development of neuropathic pain in diabetic rats: Involvement of oxidative stress and inflammation.
    Kiasalari Z; Rahmani T; Mahmoudi N; Baluchnejadmojarad T; Roghani M
    Biomed Pharmacother; 2017 Feb; 86():654-661. PubMed ID: 28033582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.
    Prnova MS; Kovacikova L; Svik K; Bezek S; Elmazoğlu Z; Karasu C; Stefek M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):651-661. PubMed ID: 31802170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.
    Hotta N; Akanuma Y; Kawamori R; Matsuoka K; Oka Y; Shichiri M; Toyota T; Nakashima M; Yoshimura I; Sakamoto N; Shigeta Y
    Diabetes Care; 2006 Jul; 29(7):1538-44. PubMed ID: 16801576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
    Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
    Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels.
    Singh P; Bansal S; Kuhad A; Kumar A; Chopra K
    Food Funct; 2020 May; 11(5):4548-4560. PubMed ID: 32400767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of ferulic acid alone and in combination with insulin in streptozotocin induced diabetic neuropathy in Sprague Dawley rats.
    Dhaliwal J; Dhaliwal N; Akhtar A; Kuhad A; Chopra K
    Life Sci; 2020 Aug; 255():117856. PubMed ID: 32473246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tetrahydropalmatine alleviated diabetic neuropathic pain by inhibiting activation of microglia via p38 MAPK signaling pathway].
    Cheng LZ; Zhou JM; Ma JL; Wang FJ; Cheng K; Chen Q; Yuan HL; Jiang AJ
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2533-2540. PubMed ID: 35531701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats.
    Kumar NP; Annamalai AR; Thakur RS
    Indian J Exp Biol; 2009 Sep; 47(9):737-42. PubMed ID: 19957886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.